Therapies

Kedrion Biopharma’s line of plasma-derived therapies is broad and diverse. With products to treat or prevent many rare diseases and conditions from hemolytic disease of the fetus and newborn to immune deficiencies to hemophilia, Kedrion Biopharma offers a wide and expanding array of treatments and therapies.

US PRODUCT PORTFOLIO

RARE AND ULTRA-RARE DISEASES/COAGULATION DISORDERS                                                                    

RYPLAZIM   
Plasma-derived human Plasminogen
COAGADEX   
Human coagulation Factor X
KOĀTE*
Human coagulation Factor VIII

IMMUNOLOGY/NEUROLOGY                                                               

GAMMAPLEX  
Human normal i.v. Immunoglobulin 5% and 10%
GAMMAKED*
Human normal i.v. Immunoglobulin 10%

CRITICAL CARE

KEDBUMIN / ALBUKED*/ALBUMINEX
Human Albumin solution
KEDRAB*
Human Rabies Immunoglobulin

MOTHER AND CHILD HEALTH

RhoGAM
Human Anti D Immunoglobulin

 

 

 

*Products distributed by Kedrion as of November 2023